EDUCATION > Courses and Products > E-Learning > Videos/Webcasts > 2013 Annual Meeting Webcasts > Prostate Cancer > Module 3: Management of Prostate Cancer: A Case-Based Approach

Module 3: Management of Prostate Cancer: A Case-Based Approach

Introduction/Activity Overview Statement of Need

This course will provide a practical, evidence-based approach for the management of everyday problems in the management of prostate cancer, using a case-based approach with examples from real practice. Topics will include developing appropriate screening strategies; how best to choose and follow patients on surveillance; long term data on outcomes after prostatectomy, external beam radiotherapy, and brachytherapy for low and intermediate risk disease; the integration of genomic based tests in patient management; an overview of the mechanism of action, potential benefits and appropriate use of newer agents for castrate-resistant disease, including immunotherapy, chemotherapy, new classes of antiadrogenic therapy, and bone-targeted agents. The course will be of interest to individuals at all levels of clinical experience.

Learning Objectives

After participating in this activity, participants should be able to:

  • design appropriate screening strategies based on individual demographics, risk factors, and PSA history and to incorporate new biomarkers into routine clinical practice
  • distinguish the use of new genomic based tests for decisions on re-biopsy and surveillance
  • appraise the role of surveillance, focal therapy, surgery, and various forms of radiation therapy in patients with low and intermediate risk disease, including adjuvant and salvage radiation
  • enumerate and contrast the benefits and drawbacks of surgery vs. radiation-based approaches for the management of high risk localized disease
  • describe new therapeutic agents for the management of castrate resistant disease and outline a coherent strategy for their use

Faculty/Authors Disclosures

Eric A. Klein, MD, Director
Chairman, Glickman Urologic and Kidney Institute
Cleveland Clinic
Cleveland, OH

Robert Dreicer, MD, Faculty
Professor and Chair Dept of Solid Tumor Oncology
Cleveland Clinic
Cleveland, OH

Andrew J. Stephenson, MD, Faculty
Associate Professor
Cleveland Clinic
Cleveland, OH

Name

Company

Relationship

Financial

Robert Dreicer, MD Janssen Consultant or Advisor, Meeting Participant or Lecturer Yes
       
Eric A. Klein, MD Abbott Diagnostics Scientific Study or Trial No
       
Andrew J. Stephenson, MD Amgen Consultant or Advisor, Meeting Participant or Lecturer Yes
       

Acknowledgement for Support

Support provided by educational grants from the following companies:

Abbvir Algeta AMGEN Astellas
Bayer Janseen Medivation Millennium

Eric A. Klein, MD
Robert Dreicer, MD
Andrew J. Stephenson, MD
Management of Prostate Cancer: A Case-Based Approach AUA2013 – Part 1


Eric A. Klein, MD
Robert Dreicer, MD
Andrew J. Stephenson, MD
Management of Prostate Cancer: A Case-Based Approach AUA2013 – Part 2

ADVERTISEMENT

ADVERTISEMENT
Donate
Contact
Press/Media
Sections
Term of Use
Site Map


ADVERTISEMENT